Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer.

Oh, Joowon; Kim, Yu Ri; Kim, Yoonjung; Kim, Boyeon; Park, Kyung Sun; Nam, Seong-Hyeuk; Lee, Kyung-A.

Afiliação

Oh J; Department of Laboratory Medicine, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates.
Kim YR; Division of hematology, Department of internal medicine, Yonsei University College of Medicine, Seoul, Korea.
Kim Y; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Kim B; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Park KS; Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.
Nam SH; SD Genomics Co., Ltd., Seoul, Korea.
Lee KA; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

J Cancer ; 12(14): 4288-4294, 2021.

Article em En | MEDLINE | ID: mdl-34093829

Palavras-chave

clonal hematopoiesis of indeterminate potential; germline predisposition to cancer; hematologic malignancy; next-generation sequencing; therapy-related myeloid neoplasms

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article